BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 7.08.1998

Determination That Acyclovir 200-Milligram Tablets Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA) is announcing its determination that acyclovir 200-milligram (mg) tablets were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDA's) for acyclovir 200-mg tablets.

Source: Federal Register — Food and Drug AdministrationOpen original release →